Pharmed Pharmaceutical Pty Ltd has sold a 65% stake to Imperial Holdings Limited
Lenmed Health Pty Ltd has sold a 65% stake in Pharmed Pharmaceutical Pty Ltd to Imperial Holdings Limited for US$10 million.
Pharmed Pharmaceutical Pty Ltd distributes pharmaceutical and other healthcare products in South Africa. The company was founded in 1985 in Overport, Durban by a group of healthcare professionals from previously disadvantaged communities.
Imperial Holdings Limited is a JSE-listed, South African-based international group of companies active in three major areas of mobility: consumer and industrial logistics, vehicle import, distribution, dealerships, retail, rental and aftermarket parts and vehicle-related financial services. The company employs around 52,000 people who generate revenues in excess of US$7.5 billion per year in Africa, Europe, South America, Australia and the USA through five major divisions which operate under separate management structures to enable decentralized entrepreneurial creativity within the group’s clearly defined strategic, capital, budgetary and governance principles.
Lenmed Health is an established black owned hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana and managing in excess of 1,300 beds.
Oaklins' team in South Africa advised the seller in this transaction.
Talk to the deal team
Related deals
Combo Group has been acquired by Heniff Transportation Systems
US-based Heniff Transportation Systems has acquired Combo Group. With this transaction, Heniff Transportation Systems immediately expands its presence in the European market, in line with its strategy to grow bulk transportation operations across the region.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn more